But even in low-bleeding-risk patients, DAPT or SAPT still leads to GI injury post-PCI, study finds
In patients at low bleeding risk, antiplatelet therapy resulted in gastrointestinal (GI) mucosal injury after percutaneous coronary intervention (PCI) during 12-month follow-up regardless of antiplatelet regimen used, although clinically evident bleeding was infrequent, according to new study results.